1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-24.88%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Other expenses reduction while RVPH shows 0.00% growth. Joel Greenblatt would examine efficiency.
-27.70%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
-27.70%
Both companies reducing total costs. Martin Whitman would check industry trends.
-8.45%
Both companies reducing interest expense. Martin Whitman would check industry trends.
No Data
No Data available this quarter, please select a different quarter.
27.70%
EBITDA growth exceeding 1.5x RVPH's 5.85%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
27.70%
Operating income growth exceeding 1.5x RVPH's 7.11%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
-27.70%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
117.18%
Tax expense growth above 1.5x RVPH's 52.58%. Michael Burry would check for concerning trends.
-117.18%
Net income decline while RVPH shows 5.90% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
-117.27%
EPS decline while RVPH shows 7.69% growth. Joel Greenblatt would examine position.
-117.27%
Diluted EPS decline while RVPH shows 7.69% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.